1993
DOI: 10.1016/0378-4347(93)80141-p
|View full text |Cite
|
Sign up to set email alerts
|

Determination of tetrahydropapaveroline in the urine of Parkinsonian patients receiving l-dopa—carbidopa (Sinemet) therapy by high-performance liquid chromatography

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
19
0

Year Published

1995
1995
2010
2010

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 21 publications
(19 citation statements)
references
References 13 publications
0
19
0
Order By: Relevance
“…The regiochemistry of THP with four phenolic hydroxyl groups suggests a precursory relationship to morphine alkaloids. Indeed this potential role as precursor for morphine had already been suggested (13,17,21,23,(26)(27)(28)), but never experimentally tested. This attractive hypothesis was investigated to see whether THP is transformed by live mice into a phenolcoupled morphine precursor.…”
Section: Resultsmentioning
confidence: 99%
“…The regiochemistry of THP with four phenolic hydroxyl groups suggests a precursory relationship to morphine alkaloids. Indeed this potential role as precursor for morphine had already been suggested (13,17,21,23,(26)(27)(28)), but never experimentally tested. This attractive hypothesis was investigated to see whether THP is transformed by live mice into a phenolcoupled morphine precursor.…”
Section: Resultsmentioning
confidence: 99%
“…Administration of L-DOPA results in the conversion of L-DOPA to dopamine (DA) in brain and leads to a replenishment DA in the surviving neurons. Tetrahydropapaveroline (THP; 6,7-dihydroxy-1-(3¢,4¢-dihydroxybenzyl)-1,2,3,4-tetrahydroisoquinoline), a metabolite of dopamine, has been detected in the urine of PD patients on L-DOPA medication [7][8][9], and in the brain and urine of rat treated with L-DOPA [10].…”
Section: Introductionmentioning
confidence: 99%
“…However, it must be specified that the work supporting these suggestions has been performed on nonhuman or cellular systems. The presence of this compound is particularly evident in the plasma, urine, and brain of parkinsonian patients treated with L-dopa [2,3,7]. It has also been identified in the brain of rats treated with L-dopa [8].…”
Section: Introductionmentioning
confidence: 90%